NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis.
Kim Han, Rachael J Klein, Thomas C Recupero...
https://pubmed.ncbi.nlm.nih.gov/42048163/Actively Recruiting
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-08-04
5000
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are studying individuals with known or suspected metabolic, inflammatory, or genetic diseases that may increase the risk of heart and blood vessel diseases. This includes affected individuals, their unaffected relatives, and healthy volunteers. The study aims to better understand rare and uncommon cardiovascular diseases, their causes, and natural history, as well as genetic factors that may influence these conditions. The research is conducted by the National Heart, Lung, and Blood Institute and includes participants aged 1 to 100 years. Participants may undergo a variety of tests tailored to their specific condition, including photography of the face and body, body measurements, chest or limb x-rays, metabolic stress tests, echocardiography, cardiovascular MRI and angiography, CT angiograms, PET imaging, six-minute walk tests, and vascular ultrasounds. Blood, tissue, and other samples may be collected either during the study or surgical procedures for research purposes. Different groups include individuals with cardiovascular-related pathologies, children affected or related to affected individuals, and healthy adult volunteers. During the study, participants will have assessments of heart, lung, and muscle function and provide specimens for ongoing disease diagnosis and genetic counseling. Questionnaires and evaluations will help researchers understand disease mechanisms and progression. Some follow-up studies may occur under separate research protocols. Participation involves various imaging, laboratory tests, and clinical evaluations to gather detailed information about cardiovascular health and related disorders.
CONDITIONS
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
R
Rebecca D Huffstutler, C.R.N.P.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Heart, Lung, and Blood Institute (NHLBI)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies by participant
Participants undergo various tests such as imaging scans, heart and lung function tests, and sample collection to study cardiovascular health and disease.
Multiple visits for assessments and sample collection
Duration - Varies by participant
Follow-up studies may be conducted under separate research protocols to further understand disease progression and outcomes.
Follow-up visits as needed
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Kim Han, Rachael J Klein, Thomas C Recupero...
https://pubmed.ncbi.nlm.nih.gov/42048163/Kim Han, Komudi Singh, Matthew J Rodman...
https://pubmed.ncbi.nlm.nih.gov/33723462/Kim Han, Komudi Singh, Allison M Meadows...
https://pubmed.ncbi.nlm.nih.gov/37586364/National Heart, Lung, and Blood Institute (NHLBI)
Lead Sponsor